Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

VA Changes Infliximab Biosimilars; Merck Formulary Win Could Drive Questions On Patient Switching

Oct 10 2018

• By Derrick Gingery

Anti-recessionary injection (vaccination) by hundred dollar denomination close up on a black background

Additional Topics

United States Biosimilars Pricing Debate Government Payers Policy Reimbursement Immune Disorders BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window